{"name":"Sichuan Huiyu Pharmaceutical Co., Ltd","slug":"sichuan-huiyu-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"sichuanhuiyu.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ferric Carboxymaltose Injection [Injectafer®]","genericName":"Ferric Carboxymaltose Injection [Injectafer®]","slug":"ferric-carboxymaltose-injection-injectafer","indication":"Other","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ferric Carboxymaltose Injection","genericName":"Ferric Carboxymaltose Injection","slug":"ferric-carboxymaltose-injection","indication":"Iron deficiency anemia in adults","status":"marketed"}]}],"pipeline":[{"name":"Ferric Carboxymaltose Injection [Injectafer®]","genericName":"Ferric Carboxymaltose Injection [Injectafer®]","slug":"ferric-carboxymaltose-injection-injectafer","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ferric Carboxymaltose Injection","genericName":"Ferric Carboxymaltose Injection","slug":"ferric-carboxymaltose-injection","phase":"marketed","mechanism":"Ferric carboxymaltose delivers iron as a stable complex that is taken up by iron-binding proteins to replenish depleted iron stores and restore hemoglobin synthesis.","indications":["Iron deficiency anemia in adults","Iron deficiency anemia in patients with chronic kidney disease","Iron deficiency anemia in patients intolerant to or with inadequate response to oral iron"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOU201SDhxa0hQdjVXdW5CUFU4OTVmbzIwYmRuNDRtNGpSanFUUmtKY0FLbGphMzlWeXBNamlDQUR0Z2pDaVFyaEk4Q24tTWpJZVN3Q3RKQ0dlUEtwQ3BwRV9wUFd0VUZ2WHVUZEVwYnlsLXNybklSbUpqRVBYcjlDTkgtcXFQNk9QcTVPaUNneDFlZFVNMEdaWDhVTjFCUDFOdll1dlB1NW80cm5sakhaWWFGWGs1UQ?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Sichuan Huiyu Pharmaceutical Hits Day High with 6.98% Surge - Markets Mojo","headline":"Sichuan Huiyu Pharmaceutical Hits Day High with 6.98% Surge","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-25","type":"pipeline","source":"simplywall.st","summary":"Lacklustre Performance Is Driving CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) 27% Price Drop - simplywall.st","headline":"Lacklustre Performance Is Driving CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) 27% Price Drop","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-09","type":"pipeline","source":"simplywall.st","summary":"One CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analyst Just Made A Major Cut To Next Year's Estimates - simplywall.st","headline":"One CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analyst Just Made A Major Cut To Next Year's Estimates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1jZG1vT21CamEtSlotV08zQ3RveHBaalpaZ2I1aFBaeHUwSTJKa29qdGxMMnQzekFmQms4UEtxdGlPdm4yZUZWMkhLNVNfNlhORHc?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"LSH Stock Price, News & Analysis - Stock Titan","headline":"LSH Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5JSXhjTGpWeDJrREI2ZkN1M0g3a1pTRHpCU0ppdklLVDhwQ2xib3hMV1VyOXhPMFZvNXFSNG9YV0tyRWFIR2wwV2NiOUVNVWtLMFA3NW1aT0tjUTBycE1MSVR1Njdvai1IQXVBZEVXVDl1amZLWkRWUzY1V2thZw?oc=5","date":"2024-11-03","type":"pipeline","source":"The Wire China","summary":"Big Pharma Doubles Down on China - The Wire China","headline":"Big Pharma Doubles Down on China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTEFVX3lxTE1TM3BUbWtUNnhiS045VDlJZjRZem1sWkRsa243dVNiRTNKM3Y3Ym11WWRwWVd5OTZtRWRpeGQ1a0tqOEFrSjZXdEZ4U2k?oc=5","date":"2024-06-28","type":"earnings","source":"Stock Titan","summary":"Latest LSH News - Lakeside Announces Fiscal 2025 Third Quarter... - Stock Titan","headline":"Latest LSH News - Lakeside Announces Fiscal 2025 Third Quarter...","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}